Amlodipine Besylate/Telmisartan

苯磺酸氨氯地平/替米沙坦

Report date: 2026/03/23 20:03:44

Base Information

Drug NameAmlodipine Besylate/Telmisartan
Drug Alias NameTelmisartan - amlodipine besylateテルミサルタン・アムロジピンベシル酸塩配合剤替米沙坦/苯磺酸氨氯地平替米沙坦-苯磺酸氨氯地平Amlodipin/Telmisartan +[9] 
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated calcium channel blockersAngiotensin II Receptor Type 1 antagonists
TargetsAngiotensin II Receptor Type 1Voltage-gated calcium channel
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryUnited States
Original Approved Date2009/10/16
Country/TerritoryCzechiaBulgariaUnited States +[16] 
CombinationsYes Amlodipine BesylateTelmisartan
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg
China Registration ClassN/A

Develop Information

Active CompaniesC.H. Boehringer Sohn Ag & Co. KgBoehringer Ingelheim International Gmbh
Inactive CompaniesJiangxi Shimei Pharmaceutical Co Ltd
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09DB04
Related LinksKEGG